Reports
Take a look at this month’s industry headlines including a new partnership for antibiotic development, approval for HIV drugs and authorization for a cytomegalovirus test.
Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.
Positive results for zoliflodacin, EMA approval for fexinidazole and Merck cuts rotavirus commitment – take a look a the month’s industry headlines.
Glenn Tillotson gives us an overview of the CDiff Foundation’s 6th annual educational meeting, including updates on new C. difficile IDSA/SHEA clinical guidelines and patient perspectives.
In this infographic we take a look at the estimated burden of healthcare-associated infections in acute care hospitals across Europe.
We look at some of the highlights of our Twitter chat (#TalkFungi), where we questioned Ilan Schwartz, Andrej Spec, Rebecca Drummond and Jessie Uehling about all things mycology.
Join us for our Twitter chat with experts in the field on the 2 October at 15:00 BST/ 10:00 EDT, discussing fungal diseases, their burden and the challenges that face them #TalkFungi.
Here we review five of your favorite and most-read pieces from Future Microbiology from last year, give you access to the articles and provide an update from the authors on how their work is progressing.
We take a look at the drugs that have been studied as treatments for confirmed prion diseases in humans – either in clinical trials, or on a compassionate, case-by-case basis – and look at what the future might hold for the treatment of prion diseases.
Janet Daly, an Associate Professor in Emergent Viruses at the University of Nottingham’s School of Veterinary Medicine and Science, tells us what advice she’d give her former self if she was back at the start of her research career.
